HomeAI · summaries
Storia in 3 fonti
Dr. Reddy's Launches Generic Semaglutide In Canada, Expands GLP-1 Push - Dr Reddy's Laboratories (NYSE:RD
Dr. Reddy's launched generic Semaglutide Injection in Canada, expanding its GLP-1 portfolio and strengthening its affordable diabetes treatment presence.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Margin revival, Semaglutide launch to drive Dr Reddy’s growth momentum in FY27
Dr Reddy's Laboratories anticipates a gradual recovery this fiscal year. The company faced a profit drop last year due to US business pressures. However, operations in India,…
- ·
thehindubusinessline.com
Dr Reddy’s launches its generic Semaglutide injection in Canada
Dr. Reddy’s launches generic Semaglutide Injection in Canada, marking the first G7 approval for this diabetes treatment.
